Innovative use of the VIVO system by Catheter Precision in Turkey for a pediatric patient

Catheter Precision, Inc., a US company specializing in medical devices for electrophysiology, recently used its VIVO system on a pediatric patient in Turkey. This deployment marks a first for this product in the country. This innovation comes just after the announcement in January of a new distribution partnership with Ege Artimi in Turkey. Catheter Precision CEO David Jenkins highlighted the benefits of VIVO, particularly for pre-operative planning in pediatrics, thanks to its non-invasiveness and ability to provide accurate information without additional risks to patients.

The VIVO system, with US FDA marketing approval and European CE marking, is designed to non-invasively identify the origin of ventricular arrhythmias before interventions, thereby reducing procedure times . This use in a young patient in Turkey illustrates the flexibility and numerous benefits of this innovative tool in sensitive populations.